REACT Score, a Novel Scoring System, Improves the Prediction of Non‐Elective Readmissions in Patients With Decompensated Cirrhosis
- 14 April 2026
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 46 (5) , e70639
Abstract
Background and Aim: One third of patients with cirrhosis experience an early readmission, and predicting such an event is challenging. We developed and validated a scoring system to predict non‐elective readmissions in patients with cirrhosis. Methods: An observational and multicenter retrospective study enrolled 1382 consecutive non electively admitted patients with cirrhosis and acute decompensation from 20 centers in Spain and were categorized as derivation and validation cohorts. The cohorts were followed for 90 days after discharge. Results: The rate of 7‐day, 30‐day and 90‐day readmission was 5.3%, 19.9% and 36.7%, respectively, while 12.3% of patients died during the study. History of decompensation [HR 1.31 (95% CI 1.04–1.64); p = 0.022], Charlson index [HR 1.08 (95% CI 1.02–1.14); p = 0.012], large‐volume paracentesis [HR 1.37 (95% CI 1.09–1.73); p = 0.007], INR [HR 1.52 (95% CI 1.17–1.97); p = 0.001] and bilirubin [HR 1.03 (95% CI 1.001–1.05); p = 0.045] at prior discharge were associated with early readmission. REACT score distinguished patients at high versus low risk of readmission: (a) derivation cohort 19.6% vs. 0% for 7‐day, 70.6% vs. 2.5% for 30‐day, 91.1% vs. 20.2% for 90‐day; (b) internal validation 20.6% vs. 0% for 7‐day, 58.8% vs. 0.5% for 30‐day, 72.1% vs. 11.8% for 90‐day; (c) external validation 5.8% vs. 0% for 7‐day, 24.6% vs. 0% for 30‐day, 44.2% vs. 12% for 90‐day. Also, high‐risk patients were more likely to be readmitted before their scheduled follow‐up appointment (51.9% vs. 5.7%). Conclusions: Cirrhosis readmission rate was 20% within the first 30 days after discharge. REACT score effectively predicted the risk of non‐elective readmission in patients with decompensated cirrhosis. Prospective studies are needed to fully assess the usefulness of this scoring system in predicting non‐elective readmissions and in developing strategies to prevent them.Keywords
Funding Information
- Instituto de Salud Carlos III (PI22/01345)
- Instituto de Salud Carlos III (GLD24/25635)
- Instituto de Salud Carlos III (FORT23/00008)
- Instituto de Salud Carlos III (PI25/01825)
This publication has 31 references indexed in Scilit:
- Patient-Reported Outcome Measures Modestly Enhance Prediction of Readmission in Patients with CirrhosisClinical Gastroenterology and Hepatology, 2022
- Impact of Readmission for Variceal Upper Gastrointestinal Bleeding: A Nationwide AnalysisDigestive Diseases and Sciences, 2021
- Thirty‐Day Readmission and Cost Analysis in Patients With Cirrhosis: A Nationwide Population‐Based DataHepatology Communications, 2020
- Predictive models of mortality and hospital readmission of patients with decompensated liver cirrhosisDigestive and Liver Disease, 2019
- Validation of Risk Score in Predicting Early Readmissions in Decompensated Cirrhotic Patients: A Model Based on the Administrative DatabaseHepatology, 2019
- HEPACONTROL. A program that reduces early readmissions, mortality at 60 days, and healthcare costs in decompensated cirrhosisDigestive and Liver Disease, 2018
- Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort StudyClinical Gastroenterology and Hepatology, 2016
- The 3‐month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosisHepatology, 2016
- Regression Modeling Strategies2015
- An Automated Model Using Electronic Medical Record Data Identifies Patients With Cirrhosis at High Risk for ReadmissionClinical Gastroenterology and Hepatology, 2013